Next Article in Journal
Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease
Previous Article in Journal
Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy
Previous Article in Special Issue
Carrier-Mediated Delivery of Low-Molecular-Weight N-Containing Drugs across the Blood–Brain Barrier or the Blood–Retinal Barrier Using the Proton-Coupled Organic Cation Antiporter
 
 
Review

Article Versions Notes

Future Pharmacol. 2024, 4(2), 336-351; https://doi.org/10.3390/futurepharmacol4020019
Action Date Notes Link
article xml file uploaded 29 April 2024 08:50 CEST Original file -
article xml uploaded. 29 April 2024 08:50 CEST Update https://www.mdpi.com/2673-9879/4/2/19/xml
article pdf uploaded. 29 April 2024 08:50 CEST Version of Record https://www.mdpi.com/2673-9879/4/2/19/pdf
article html file updated 29 April 2024 08:52 CEST Original file https://www.mdpi.com/2673-9879/4/2/19/html
Back to TopTop